| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/07/2004 | EP1404696A1 Activators for oligonucleotide synthesis |
| 04/07/2004 | EP1404695A2 Universal supports for oligonucleotide synthesis |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP0979277B1 Novel human tumour suppressor gene |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487084A Rice root system phosphorus starvation induction specific expression promoter and its plant culture method |
| 04/07/2004 | CN1487083A Rockfish insulin-like growth factor Ôàí gene, carrier and recombinant strain containing the gene and their application |
| 04/07/2004 | CN1487080A Alkaline protease |
| 04/07/2004 | CN1144811C Dinucleotide crystals |
| 04/06/2004 | US6716994 Fluorescence based four color nucleic acid sequencing |
| 04/06/2004 | US6716975 Antisense modulation of EDG1 expression |
| 04/06/2004 | US6716971 Pteridine nucleotide analogs |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716627 Mucin 1, transmembrane may help to frustrate infection in the mammary gland (mastitis) and possibly in other sites in the body (such as bladder and kidney infections) by competitively inhibiting the binding of microorganisms |
| 04/06/2004 | US6716603 Nucleic acids encoding a chloride channel protein |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/06/2004 | US6716581 Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility |
| 04/06/2004 | US6716580 Method for the automated generation of nucleic acid ligands |
| 04/06/2004 | US6716576 Method of assaying Neutrokine-α mRNA level |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716430 Moderating immunology response |
| 04/06/2004 | CA2174140C Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
| 04/06/2004 | CA2089563C Oligonucleotide modulation of cell adhesion |
| 04/01/2004 | WO2004027082A2 Methods and compositions for detecting targets |
| 04/01/2004 | WO2004027081A2 Methods and composition for detecting targets |
| 04/01/2004 | WO2004027080A2 Method of extracting nucleic acids from microbial samples |
| 04/01/2004 | WO2004027075A2 Chemoenzymatic methods for the synthesis of statins and stain intermediates |
| 04/01/2004 | WO2004027054A1 Thermostable rna ligase from thermus phage |
| 04/01/2004 | WO2004027043A2 Method for production of a multimeric protein by cell fusion |
| 04/01/2004 | WO2004026931A2 Functionalized materials and methods of using same |
| 04/01/2004 | WO2004026804A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 04/01/2004 | WO2004026329A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | WO2004026266A2 SYNTHESIS AND APPLICATIONS OF TRINUCLEOTIDE pCpCpA-3′-NH-AMINOACYL DERIVATIVES |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026109A2 Molecular targets of cancer and aging |
| 04/01/2004 | WO2004020675A3 Polymorphism detection among homologous sequences |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004005889A3 Detection of drug-resistant human immunodeficiency virus |
| 04/01/2004 | WO2004005460A3 Antisense modulation of hmg-coa reductase expression |
| 04/01/2004 | WO2003106652A3 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/01/2004 | WO2003106630A3 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 04/01/2004 | WO2003104685A3 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof |
| 04/01/2004 | WO2003102131A3 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2003087765A3 System for tracing animal products |
| 04/01/2004 | WO2003075837A3 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins |
| 04/01/2004 | WO2003063773A3 Differentially-regulated prostate cancer genes |
| 04/01/2004 | WO2003029405A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/01/2004 | US20040063925 Amplification; polymerase chain reaction |
| 04/01/2004 | US20040063924 Comprises nucleotide sequences coding membrane proteins for treatment diagnosis and prevention of cell proliferative, inflammatory, autoimmune, nervous system, cardiovascular and developmental disorders |
| 04/01/2004 | US20040063922 Ester interchange; autocatalyst; genetic engineering; gene therapy for genetic disorders |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063909 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders |
| 04/01/2004 | US20040063655 Antisense modulation of transforming growth factor-beta expression |
| 04/01/2004 | US20040063653 Devoid of protease, reverse transcriptase, RNase H and integrase activity |
| 04/01/2004 | US20040063638 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063635 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063141 Cell surface display of proteins by recombinant host cells |
| 04/01/2004 | US20040063115 Comprises catalyst polypeptides for diagnosis, prevention and treatment of cell proliferative, autoimmune, inflammatory, cardiovascular, gastrointestinal, neurological, respiratory, sexual vision disorders |
| 04/01/2004 | US20040063114 Tag library compounds, compositions, kits and methods of use |
| 04/01/2004 | US20040063107 Novel proteases |
| 04/01/2004 | US20040063101 Comprises nucleotide sequences coding cancer/testis (CT) antigen for diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/01/2004 | US20040062777 Genetic engineered polypeptides; enzyme inhibitors |
| 04/01/2004 | CA2767235A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | CA2499360A1 Methods and compositions for detecting targets |
| 04/01/2004 | CA2499077A1 Methods and composition for detecting targets |
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | CA2498320A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/31/2004 | EP1402068A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401854A2 Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression |
| 03/31/2004 | EP1401852A2 Methods for preparing oligonucleotides having chiral phosphorothioate linkages |
| 03/31/2004 | EP1401851A1 Two-stage protective groups for the synthesis of biopolymers |
| 03/31/2004 | EP1401850A1 Nucleoside derivatives for library preparation |
| 03/31/2004 | EP1401849A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/31/2004 | EP0853680B1 Method for precipitating nucleic acid with visible carrier |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1485340A Polypeptide-human transmembrane glycopeptide 25 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485339A Polypeptide-human zinc finger protein 70 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485338A Polypeptide -Human vacuole carrier protein 13 and polynucleotide for encoding this polypeptide |
| 03/31/2004 | CN1485337A Polypeptide-human actin heavy chain 74 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485336A Polypeptide- human clathrin 82 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485335A Polypeptide-embryonic development protien 65 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485334A Polypeptide-human I complement receptor protein 222 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485333A Polypeptide-human X linked gene espression protein 14 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485332A Polypeptide-human ª‰transducin 72 and polynucleotide for coding the same |
| 03/31/2004 | CN1143892C Recombinant sendal virus |